Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
  •  
Login | Create an Account

2019 Hospital Practice Seminar • CPE


Conference

The University of Texas College of Pharmacy welcomes you to the Hospital Practice Seminar.  This CE seminar will focus on the educational needs of hospital and clinical pharmacists. The Seminar will take place on June 14-15, 2019 at the DoubleTree by Hilton in Austin, Texas.  The Hospital Practice Seminar’s (HPS) mission is to provide important updates relevant to today’s hospital & clinical-based pharmacists  The HPS promotes a culture of collaboration, creativity and innovation. This year there will be a emphasis on Infectious Dieases. 
 
Registration includes access to all CE activities, education content and copies of presentations, beverages and meals (breakfast and lunch for each day, including snacks). 

The content of this conference is based on practice gaps that are identified by surveying pharmacists, physicians and technicians who work in hospital settings, through discussions with the planning committee, and by analyzing current practice trends.  Participants will receive evidence-based clinical information that is relevant to hospital-based practices.  Speakers who have been recommended by the planning committee as outstanding presenters and experts in their practice will deliver the featured presentations.

Each session in the conference is formatted to include: a didactic evidence-based presentation, opportunities for active learning through the use of case studies, and Q&A discussion that allows audience members to ask specific questions for individualized learning.   The information delivered at this conference is intended to be in-depth, yet practical enough that participants will immediately put it to use upon return to their practice.  The content may be used to implement individualized, comprehensive and evidence-based treatment plans for patients.

 

Quick Links:  Event Home Page  •  Agenda  •  Location  •  Speakers  •  Lodging  •  CE Information  •  Contact

Refund Policy:  A refund of the seminar registration fee minus a $50 transaction fee will be made if notification of cancellation is made to College of Pharmacy Continuing Education by May 15.  Refunds will not be made for cancellations received after May 15; however, substitute registrants will be accepted with prior notification.
 

Date: Jun 14, 2019 01:00 AM - Jun 15, 2019 11:55 PM

Fee

$495.00

CE Hours

20.75

CE Units

2.075

Registration closes on Jun 15, 2019 11:55 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

“This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit.  The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

ACPE Logo
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This two-day seminar includes a total 19.75 hours of CE programming from which pharmacists may earn a maximum of 15.75 CE credit hours.  In order to receive 15.75 contact hours of CE credit, the participant must attend/participate in all sessions of the seminar and complete the online Evaluations at the conclusion of each session and the overall seminar.
 
Pharmacists: Must Complete CPE Evaulations by August 5, 2019 or Forfeit CPE Credit
As of May 1, 2014, ACPE has placed a strict limit of 60 days to complete the CPE requirements for credit for all pharmacy continuing education programs.  Pharmacists who fail to complete the requirements for credit for this program will forfit CPE credit for this activity.  Per rule set by ACPE, The University of Texas at Austin College of Pharmacy will not be able to process credit after the 60 day deadline, and will not be able to route credits to the NABP eProfiles. 

 

 

Registration closes on Jun 15, 2019 at 11:55 PM

Registration Closed  

Date: 06/14/19
Time: 08:00 AM - 08:00 AM
Registration Closed  

Registration Closed  

Breakfast buffet in the conference pre-function area.
 
Date: 06/14/19
Time: 07:00 AM - 08:00 AM
Registration Closed  

Registration Closed  

Date: 06/14/19
Time: 08:00 AM - 08:15 AM
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Discuss the importance and strategies of maintaining a good work-life balance.
  • Identify effective strategies to enhance your ability to precept/guide members of your pharmacy team.
  • Solve challenging preceptor and student/resident scenarios that are common issues faced in the experiential learning environment.

Speaker(s)/Author(s)

Craig Cox, Pharm.D.
Associate Professor, Texas Tech University HSC School of Pharmacy

Activity Number

0067-0000-19-051-L04-P/T
Date: 06/14/19
Time: 08:00 AM - 09:10 AM

CE Hours

1.25
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • o Summarize the key changes to the most recent AHA Advanced Cardiac Life Support Guidelines.
  • o Assess the storage and use of medications intended for emergent situations at their institution.
  • o Identify and overcome barriers to safe and effective medication use in emergencies.

Speaker(s)/Author(s)

Daniel Giddings, Pharm.D.
PGY1 Resident, The University of Texas at Austin College of Pharm

Activity Number

0067-0000-19-052-L01-P/T
Date: 06/14/19
Time: 09:15 AM - 10:40 AM

CE Hours

1.50
Registration Closed  

Registration Closed  

Date: 06/14/19
Time: 10:45 AM - 11:00 AM
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Cite recent changes in pharmacy laws and rules and their impact on daily practice.

Speaker(s)/Author(s)

Allison Vordenbaumen Benz, RPh, MS
Executive Director/Secretary , Texas State Board of Pharmacy

Activity Number

0067-0000-19-053-L03-P/T
Date: 06/14/19
Time: 11:00 AM - 12:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Summarize the role of diuretics in the treatment of heart failure and chronic kidney disease.
  • Review clinical pharmacology of loop diuretics.
  • Identify common mistakes made in pharmacotherapy decisions with diuretics.
  • Apply pharmacotherapy principles to a patient case.

Speaker(s)/Author(s)

Rebecca Moote, PharmD, MSc, BCPS

Activity Number

0067-0000-19-054-L07-P/T
Date: 06/14/19
Time: 12:00 PM - 12:55 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 06/14/19
Time: 01:00 PM - 01:30 PM
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker has disclosed that she is a speaker for Acadia.

Objectives

  • o Describe common complications that occur in the early postoperative phase.
  • o Discuss pharmacologic strategies for managing postoperative complications.

Speaker(s)/Author(s)

Tricia Meyer, Pharm.D.
Director of Pharmacy, Scott & White Memorial Hospital

Activity Number

0067-0000-19-057-L01-P/T
Date: 06/14/19
Time: 01:30 PM - 02:25 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.
 

Objectives

  • Recall the critical sites of commonly used sterile compounding supplies.
  • Identify the ISO classification in a cleanroom environment.

Speaker(s)/Author(s)

Tiffany Kofroth, CPhT, CSPT, PhTR
Specialty Pharmacy Technician, The University of Texas MD Anderson

Activity Number

0067-0000-19-056-L07-P/T
Date: 06/14/19
Time: 01:30 PM - 02:25 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Describe clinical manifestations of skin rashes that appear during febrile illnesses.
  • Differentiate infectious versus non-infectious skin rashes.
  • Summarize the pharmacist’s role in the diagnosis and management of skin rashes.

Speaker(s)/Author(s)

Kathryn Merkel, Pharm.D., BCPS
Clinical Pharmacy Specialist, Pediatric Infectious Diseases , Dell Children’s Medical Center

Activity Number

0067-0000-19-055-L01-P/T
Date: 06/14/19
Time: 02:30 PM - 03:25 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Identify quality control and quality assurance procedures that should be performed within a cleanroom environment.
  • Recognize the differences between primary engineering controls.

Speaker(s)/Author(s)

Tiffany Kofroth, CPhT, CSPT, PhTR
Specialty Pharmacy Technician, The University of Texas MD Anderson

Activity Number

0067-0000-19-058-L07-P/T
Date: 06/14/19
Time: 02:30 PM - 03:25 PM

CE Hours

1.00
Registration Closed  

Registration Closed  


 
Date: 06/14/19
Time: 03:35 PM - 03:50 PM
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Understand the clinical relevance of appropriate and prompt antimicrobial therapy.
  • Describe the various technologies currently used for rapid diagnostics in the hospital setting.
  • Recognize the benefits that rapid diagnostic technology can provide for antimicrobial stewardship efforts.
  • Review various methods for implementing rapid diagnostic technology and the challenges to such implementation.

Speaker(s)/Author(s)

Gerard Gawrys

Activity Number

0067-0000-19-059-L04-P/T
Date: 06/14/19
Time: 03:45 PM - 04:40 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Discuss new regulatory requirements for antimicrobial stewardship.

Speaker(s)/Author(s)

Neesha Thakkar, PharmD, BCPS
Pharmacist Clinical Coordinator, St. David’s Medical Center

Activity Number

0067-0000-19-060-L04-P/T
Date: 06/14/19
Time: 04:45 PM - 05:25 PM

CE Hours

0.75
Registration Closed  

Registration Closed  

Date: 06/14/19
Time: 06:20 PM - 06:20 PM
Registration Closed  

Registration closes on Jun 15, 2019 at 11:55 PM

Registration Closed  

Date: 06/15/19
Time: 07:45 AM - 07:45 AM
Registration Closed  

Registration Closed  

Date: 06/15/19
Time: 07:45 AM - 08:00 AM
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Discuss the challenges hospital pharmacy leaders face in the constantly changing health care environment.
  • Describe skill sets, strengths, and other considerations that can help one effectively lead a hospital pharmacy department.
  • Examine different ways that clinicians take on formal leadership roles in the health-system setting.
  • Discuss how involvement in professional associations is imperative to advancing pharmacy practice.

Speaker(s)/Author(s)

alex varkey

Activity Number

0067-0000-19-061-L04-P/T
Date: 06/15/19
Time: 08:00 AM - 08:55 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
These panel members have all disclosed that they do not have any relevant financial relationships.

Objectives

  • Identify and optimize resources available at your facility.
  • Examine educational materials often used in frontline antimicrobial stewardship.
  • Employ a multidisciplinary approach to antimicrobial stewardship.
  • o

Speaker(s)/Author(s)

Jason Bowling

Kathryn Merkel, Pharm.D., BCPS
Clinical Pharmacy Specialist, Pediatric Infectious Diseases , Dell Children’s Medical Center

Kristi Traugott

Neesha Thakkar, PharmD, BCPS
Pharmacist Clinical Coordinator, St. David’s Medical Center

Activity Number

0067-0000-19-062-L01-P/T
Date: 06/15/19
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker has disclosed that she is a speaker for Gilead, Merck, and Abbvie.

Objectives

  • Identify situations that might warrant the interruption of Hep C therapy while in hospital care.
  • Explain harm reduction/prevention efforts that must be considered for patients in the hospital.
  • Briefly describe principles of diagnosis and management of hepatitis C.

Speaker(s)/Author(s)

Jordan Mayberry, MPAS, PA-C
Internal Medicine, UT Southwestern Medical Center

Activity Number

0067-0000-19-063-L01-P/T
Date: 06/15/19
Time: 10:00 AM - 10:55 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 06/15/19
Time: 11:00 AM - 11:20 AM
Registration Closed  

Registration Closed  

    
Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Discuss current first-line antiretroviral therapy and opportunistic infection prophylaxis.
  • Discuss the prevention of medication errors during transitions of care.
  • Identify other tips or therapy considerations (drug-drug interactions) for the care of patients with HIV.

Speaker(s)/Author(s)

Dusten Rose, Pharm D

Activity Number

0067-0000-19-064-L02-P/T
Date: 06/15/19
Time: 11:20 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker has disclosed that she is a consultant with Critical Point, author for ASHP, committee member of USP, and employee of Cardinal Health.

Objectives

  • Identify the document that must be used to create an organization’s list of hazardous drugs
  • Cite the elements required for an Assessment of Risk.
  • Describe the process for identifying alternative strategies for an Assessment of Risk as defined in USP <800>.
  • Describe the key facility elements listed in USP <800> that must be used when compounding hazardous drugs.
  • Describe the work process that differs from routine when compounding hazardous drugs (technique, use of equipment, decontaminating, cleaning, and disinfecting).

Speaker(s)/Author(s)

Patricia Kienle, MPA, BSPharm, FASHP
Director of Accreditation and Med Safety, Cardinal Health

Activity Number

0067-0000-19-065-L07-P/T
Date: 06/15/19
Time: 11:20 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.
    

Objectives

  • Name and describe recently approved antibacterial agents.
  • Discuss future antibacterial agents within the development pipeline.

Speaker(s)/Author(s)

Kelly Echevarria

Activity Number

0067-0000-19-066-L01-P/T
Date: 06/15/19
Time: 12:20 PM - 01:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Describe the types of facility engineering controls required for compliance with USP 800
  • Evaluate the challenges of implementing USP 800 at your facility
  • Identify key stakeholders in implementing USP 800
  • Determining what types of PPE are appropriate for your staff

Speaker(s)/Author(s)

Robert McClelland, Pharm D, MHA, DPLA
Dir of Pharmacy, 340B Apexus Certified Expert

Activity Number

0067-0000-19-067-L07-P/T
Date: 06/15/19
Time: 12:20 PM - 01:20 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Pick up lunches and return to the classroom.
Date: 06/15/19
Time: 01:20 PM - 01:40 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Financial Disclosure:  
Both of these speakers have disclosed they do not have any relevant financial relationships.

Objectives

  • Discuss the basic pharmacology of the new drugs presented and how the pharmacologic actions relate to both therapeutic and adverse effects.

Speaker(s)/Author(s)

Laurajo Ryan, PharmD, MSc, BCPS, CDE picture

Laurajo Ryan, PharmD, MSc, BCPS, CDE, Pharm.D., MSc, BCPS, CDE
Clinical Associate Professor, UT Austin College of Pharmacy / UTHSCSA

Activity Number

0067-0000-19-068-L04-P/T
Date: 06/15/19
Time: 01:40 PM - 02:50 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Financial Disclosure:  
This speaker does not have any relevant financial relationships to disclose.

Objectives

  • Identify the therapy that is necessary prior to the transplant procedure.
  • Describe the therapy that is required following the transplant procedure.
  • Explain considerations for long term success and plans for follow-up with patient.

Speaker(s)/Author(s)

Joelle Nelson, Pharm D

Activity Number

0067-0000-19-069-L01-P/T
Date: 06/15/19
Time: 02:55 PM - 03:50 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 06/15/19
Time: 12:00 PM - 12:00 PM
Registration Closed  

Registration Closed  

Date: 06/15/19
Time: 03:55 PM - 03:55 PM
Registration Closed  



System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 7 or higher, macOS Sierra (10.12) or higher
  • Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Internet Explorer 11, Microsoft Edge, Safari 9 or higher
  • Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones Media Viewing Requirements: Adobe Reader, HTML5
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice.Activities produced by UT Continuing Pharmacy Education are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
The University of Texas at Austin College of Pharmacy • Continuing Pharmacy Education
2409 University Ave., Stop A1904 | Austin, Texas 78712
Comments to:  UTpharmacyCE@austin.utexas.edu
College of Pharmacy, The University of Texas at Austin
 
LMS Powered By: Learning ExpressCE
Copyright © 2024 University of Texas at Austin College of Pharmacy. All Rights Reserved.
About Us Privacy Policy Terms of Service